Liver Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Apr 15, 2004; 10(8): 1137-1140
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1137
Table 1 Characteristics of 87 cirrhotic HCC patients treated with RFA
Characteristicn(%)
Gender
Male7181.6
Female1618.4
Ethiology of cirrhosis
HCV related4652.9
HBV related1112.6
HBV+HCV33.4
Alcoholic2427.7
Other causes33.4
Child-Pugh classification
A4855.2
B3944.8
C00
CLIP score
02528.7
14248.3
21921.8
411.2
Number of lesions
Single5360.9
Multiple3439.1
Morphology of HCC
Infiltrating1817.3
Noninfiltrating8682.7
Alfa-fetoprotein level
< 200 kU/L7990.8
200 kU/L89.1
Table 2 Treatment-related complications occurred in 130 pro-cedure
Events n (%)
Minor complications13 (10)
Fever (> 38 °C) and moderate pain (5-6 d)10 (7.7)
Right pleural effusion2 (1.5)
Cutaneous burn1 (0.8)
Major complications8 (6.1)
Rapid tumor progression4 (2.9)
Bacterial endocarditis1 (0.8)
Neoplastic seeding1 (0.8)
Peritoneal bleeding1 (0.8)
Hepatic decompensation1 (0.8)
Table 3 Caracteristics of four patients with rapid tumor progression after RFA
Gender, age, etiologyTumor size (cm)LocationDifferentiation
1. Male, 66 yr, alcohol3.5V segmentNear right portal trunkaPoor
2.Male, 75 yr, HCV3.8VI segmentNear segmental portal branchaPoor
3. Male, 59 yr, HBV, HCV4.5VII segmentNear cava veinPoor
3.Male, 62 yr, HBV4.5IV segmentNear segmental portal branchaModerate
Table 4 Risk factors for rapid tumor progression in 87 patients
VariablesNo tumor progression (83)Tumor progression (4)P value
Child-Pugh class
A/B45/383/10.41
CLIP score
0/1/2/425/40/17/10/2/2/00.43
Number lesions
Single/multiple50/332/20.68
AFP value
< 200/≥ 200 kU/L77/62/20.04
Tumor size
< 3 cm/3-5 cm/5-7 cm10/59/140/4/00.45
Tumor morphology
Infiltrating/15/681/30.72
noninfiltrating
Portal vein thrombosis
No/main portal71/1/33/0/10.17
branch/sectorial
Tumor location
Peripheral/near60/231/30.04
main portal
Treatment
Duration RFA (min)27.7±13.725.6±7.50.40
Number insertions2.0±1.31.7±0.90.33